W
WAVEMAN · COMPANY
NRXS · Neuraxis, Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

NRXS

Neuraxis, INC
MEDICAL DEVICES · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · CIK 0001933567
CLUSTER · 3 INSIDERSC-SUITE BUYING · 3☆ WATCH
INSIDER NET · 180D
$32.0K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
3
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
23
13F, latest reported quarter
REVENUE GROWTH
+32.9%
XBRL, annual
NET MARGIN
-218.5%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$32.0K over 180 days
more than 75% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
23 funds added or opened last quarter
below 72% of Medical Devices
REVENUE
+32.9% year over year
more than 85% of Medical Devices
MARGIN
-218.5% net margin
below 89% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
3.3% of shares outstanding short · 5.0 days to cover · settled 2026-07-31
below 52% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
3 insiders independently bought a net $32.0K — no planned sales are queued against it.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +126.6%
+126.6%12M
-12%+70%+153%+235%2025-092025-102025-122026-032026-052026-072026-09 2025-12-23 · Aharon Gil bought $1.0M2026-04-01 · Carrico Brian Allen bought $15.8K2026-04-01 · Henrichs Timothy Robert bought $14.9K2026-04-01 · Carrico Thomas Joeseph bought $1.3K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
3 insiders reported buying shares.
The record shows a net $32.0K bought by insiders over 180 days, 23 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Neuraxis, INC insiders bought a net $32.0K of stock across 6 Form 4 purchases and sales, with 3 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Henrichs Timothy Robert
Chief Financial Officer
BUY
2026-04-01
7,593.0
$14.9K
Carrico Thomas Joeseph
CRO, CCO, CPO
BUY
2026-04-01
667.0
$1.3K
Carrico Brian Allen
Chief Executive Officer
BUY
2026-04-01
8,060.0
$15.8K
Aharon Gil
Director
BUY
2025-12-23
286,138.0
$1.0M
MASIMO CORP
SELL
2025-07-01
289,779.0
$652.0K
6 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 1 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
AIGH Capital Management LLC
519,938.0 sh
$3.8M
Rosalind Advisors, Inc.
508,055.0 sh
$3.0M
VANGUARD CAPITAL MANAGEMENT LLC
335,793.0 sh
$2.5M
MONEY CONCEPTS CAPITAL CORP
228,029.0 sh
$1.7M
RENAISSANCE TECHNOLOGIES LLC
169,400.0 sh
$1.2M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Ultra-Small Company Market Fund
$37.0K POSITION · AS OF 2026-03-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$741.0K POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$254.7K POSITION · AS OF 2026-02-28
0.0%
Fidelity Series Total Market Index Fund
$75.0K POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$83.2K POSITION · AS OF 2026-02-28
0.0%
VANGUARD TOTAL STOCK MARKET INDEX FUND
$930.4K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122023-09
REVENUE$3.6M$2.7M$2.5M
GROSS PROFIT$3.0M$2.3M$2.2M
OPERATING INCOME$-7.8M$-7.2M$-6.7M
NET INCOME$-7.8M$-8.2M$-14.6M
EPS (DILUTED)-0.95-1.22-4.50
OPERATING CASH FLOW$-6.4M$-6.1M$-6.7M
CASH$5.0M$3.7M$78.6K$761.2K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →